Glial cell line-derived neurotrophic factor (GDNF) family ligands reduce the sensitivity of neuroblastoma cells to pharmacologically induced cell death, growth arrest and differentiation

Neuroscience Letters

Volumn 389, Issue 2, 2005, Pages 77-82

  Hansford, Loen M ^a   Marshall, Glenn M ^a,b  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cell growth; Differentiation therapy; GFR alpha co receptor; Glial cell line derived neurotrophic factor (GDNF) family ligands; Neuroblastoma; Ret tyrosine kinase

Indexed keywords

ANTIINFECTIVE AGENT; CISPLATIN; DOXORUBICIN; ETOPOSIDE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEURTURIN; RETINOIC ACID; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; GROWTH DISORDER; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NERVE TUMOR; NEURAL CREST; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOTOXINS; DRUG RESISTANCE, NEOPLASM; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS; GROWTH INHIBITORS; HUMANS; LIGANDS; MICE; MICE, TRANSGENIC; NEUROBLASTOMA; NEURTURIN; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 24144502484     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.07.034     Document Type: Article

References (23)

1. A. Allmendinger, E. Stoeckel, M. Saarma, K. Unsicker, and K. Huber Development of adrenal chromaffin cells is largely normal in mice lacking the receptor tyrosine kinase c-Ret Mech. Dev. 120 2003 299 304
2. R.H. Baloh, H. Enomoto, E.M. Johnson Jr., and J. Milbrandt The GDNF family of ligands and receptors - implications for neural development Curr. Opin. Neurobiol. 10 2000 103 110
3. M.W. Barnett, C.E. Fisher, G. Perona-Wright, and J.A. Davies Signalling by glial cell line derived neurotrophic factor (GDNF) requires heparin sulfate glycosaminoglycan J. Cell Sci. 115 2002 4495 4503
4. M.G. Borrello, I. Bongarzone, M.A. Pierotti, R. Luksch, M. Gasparini, P. Collini, S. Pilotti, M.G. Rizzetti, P. Mondellini, B. De Bernardi, D. Di Martino, A. Garaventa, M. Brisigotti, and G.P. Tonini trk and ret proto-oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non-advanced stages Int. J. Cancer 54 1993 540 545
5. A. Buj-Bello, V.L. Buchman, A. Horton, A. Rosenthal, and A.M. Davies GDNF is an age-specific survival factor for sensory and autonomic neurons Neuron 15 1995 821 828
6. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
7. A.M. Conti, S.J. Fischer, and A.J. Windebank Inhibition of axonal growth from sensory neurons by excess nerve growth factor Ann. Neurol. 42 1997 838 846
8. A. Eggert, N. Ikegaki, X.G. Liu, and G.M. Brodeur Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma Kind. Padiatr. 212 2000 200 205
9. M. Haber, S.B. Bordow, J. Gilbert, J. Madafiglio, M. Kavallaris, G.M. Marshall, E.B. Mechetner, J.P. Fruehauf, L. Tee, S.L. Cohn, H. Salwen, M.L. Schmidt, and M.D. Norris Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells Oncogene 18 1999 2777 2782
10. L.M. Hansford, W.D. Thomas, J.M. Keating, C.A. Burkhart, A.E. Peaston, M.D. Norris, M. Haber, P. Armati, W.A. Weiss, and G.M. Marshall Mechanisms of embryonal tumor initiation: Distinct roles for MycN expression and MYCN amplification Proc. Natl. Acad. Sci. U.S.A. 101 2004 12664 12669
11. T. Hishiki, Y. Nimura, E. Isogai, K. Kondo, S. Ichimiya, Y. Nakamura, T. Ozaki, S. Sakiyama, M. Hirose, N. Seki, H. Takahashi, N. Ohnuma, M. Tanabe, and A. Nakagawara Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary neuroblastomas expressing c-Ret, GFRα-1, and GFR α-2 Cancer Res. 58 1998 2158 2165
12. P.C. Holm, P. Åkerud, J. Wagner, and E. Arenas Neurturin is a neuritogenic but not a survival factor for developing and adult central noradrenergic neurons J. Neurochem. 81 2002 1318 1327
13. I. Ikeda, Y. Ishizaka, T. Tahira, T. Suzuki, M. Onda, T. Sugimura, and M. Nagao Specific expression of the ret proto-oncogene in human neuroblastoma cell lines Oncogene 5 1990 1291 1296
14. S. Jing, D. Wen, Y. Yu, P.L. Holst, Y. Luo, M. Fang, R. Tamir, L. Antonio, Z. Hu, R. Cupples, J-C. Louis, S. Hu, B.W. Altrock, and G.M. Fox GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF Cell 85 1996 1113 1124
15. D.C.W. Lee, K.W. Chan, and S.Y. Chan RET receptor tyrosine kinase isoforms in kidney function and disease Oncogene 21 2002 5582 5592
16. G.M. Marshall, A.E. Peaston, J.E. Hocker, S.A. Smith, L.M. Hansford, V. Tobias, M.D. Norris, M. Haber, D.P. Smith, M.J. Lorenzo, B.A.J. Ponder, and J.A. Hancock Expression of multiple endocrine neoplasia 2B RET in neuroblastoma cells alters cell adhesion in vitro, enhances metastatic behavior in vivo, and activates jun kinase Cancer Res. 57 1997 5399 5405
17. V. Pachnis, B. Mankoo, and F. Costantini Expression of the c-ret proto-oncogene during mouse embryogenesis Development 119 1993 1005 1017
18. A.E. Peaston, M.L. Camacho, M.D. Norris, M. Haber, D.J. Marsh, B.G. Robinson, V.J. Hyland, and G.M. Marshall Absence of MEN2A- or 2B-type RET mutations in primary neuroblastoma tumor tissue Mol. Cell. Probes 12 1998 239 242
19. K. Sainio, P. Suvanto, J. Davies, J. Wartiovaara, K. Wartiovaara, M. Saarma, U. Arumäe, X. Meng, M. Lindahl, V. Pachnis, and H. Sariola Glial-cell-line-derived neurotrophic factor is required for bud initiation from uteric epithelium Development 124 1997 4077 4087
20. H. Shimada, I.M. Ambros, L.P. Dehner, J. Hata, V.V. Joshi, and B. Roald Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee Cancer 86 1999 349 363
21. W.A. Weiss, T. Godfrey, C. Francisco, and J.M. Bishop Genome-wide screen for allelic imbalance in a mouse model of neuroblastoma Cancer Res. 60 1997 2483 2487
22. C.A. Worby, Q.C. Vega, Y. Zhao, H.H-J. Chao, A.F. Seasholtz, and J.E. Dixon Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase J. Biol. Chem. 271 1996 23619 23622
23. H. Yan, D.F. Newgreen, and H.M. Young Developmental changes in neurite outgrowth responses of dorsal root and sympathetic ganglia to GNDF, neurturin, and artemin Dev. Dyn. 227 2003 395 401